Posterior Uveitis
What's New
Last Posted: Jul 17, 2024
- Role of interleukin 1? and interleukin 10 variants on ocular toxoplasmosis in Brazilian individuals.
Warlen Miiller Rocha Araujo, et al. Frontiers in ophthalmology 2024 0 1183167 - Clinical Patterns of Sarcoidosis Patients with and without Uveitis: Insights from a Dutch Sarcoidosis Centre.
Sanela Ku?, et al. Ocular immunology and inflammation 2024 0 1-8 - Human toxocariasis seroprevalence among patients with uveitis in Alborz Province, Iran.
Zibaei Mohammad, et al. Annals of agricultural and environmental medicine : AAEM 2019 0 (1) 154-158 - Genetic and Clinical Features of Blau Syndrome among Chinese Patients with Uveitis.
Zhong Zhenyu, et al. Ophthalmology 2022 0 (7) 821-828 - Association between ocular toxoplasmosis and APEX1 and MYD88 polymorphism.
Aloise Débora de Almeida, et al. Acta tropica 2021 6 106006 - Contribution of HLA-B*51:01 and -A*26:01 to Behçet's disease and their clinical association in Thai patients.
Louthrenoo Worawit, et al. International journal of rheumatic diseases 2020 1 - Single Nucleotide Polymorphisms of FCRL3 in Iranian Patients with Behcet's Disease.
Shahram Farhad, et al. Iranian journal of public health 2019 6 (6) 1133-1139 - Ubiquitin Associated and SH3 Domain Containing B (UBASH3B) Gene Association with Behcet's Disease in Iranian Population.
Shahriyari Elham, et al. Current eye research 2018 10 - Lack of association of C3 gene with uveitis: additional insights into the genetic profile of uveitis regarding complement pathway genes.
Yang Ming Ming, et al. Scientific reports 2017 4 (1) 879 - New insights into the genetic component of non-infectious uveitis through an Immunochip strategy.
Márquez Ana, et al. Journal of medical genetics 2016 9
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: